Clinical Trial: Study to Test an Approved Product in the Early Treatment of Migraine

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.

Condition Treatment or Intervention Phase
Migraine
 
Phase II
Phase III

MedlinePlus related topics:  Migraine

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Six month history of migraine; attacks typically mild when they begin with 1-4 migraine attacks per month.

Exclusion Criteria:

  • Heart disease
  • High blood pressure

Location Information


Arizona
      Call for Information, Phoenix,  Arizona,  85020,  United States

California
      Call for Information, Santa Monica,  California,  90404,  United States

      Call for Information, Encinitas,  California,  92024,  United States

      Call for Information, Irvine,  California,  92618,  United States

      Call for Information, Walnut Creek,  California,  94596,  United States

Colorado
      Call for Information, Boulder,  Colorado,  80304,  United States

Connecticut
      Call for Information, Stamford,  Connecticut,  06902,  United States

Florida
      Call for Information, Palm Beach Gardens,  Florida,  33410,  United States

      Call for Information, Plantation,  Florida,  33324,  United States

      Call for Information, Daytona Beach,  Florida,  32114,  United States

      Call for Information, Pembroke Pines,  Florida,  33024,  United States

      Call for Information, Hialeah,  Florida,  33013,  United States

Georgia
      Call for Information, Decatur,  Georgia,  30033,  United States

Illinois
      Call for Information, Northbrook,  Illinois,  60062,  United States

Kansas
      Call for Information, Wichita,  Kansas,  67212,  United States

Kentucky
      Call for Information, Campbellsville,  Kentucky,  42718,  United States

      Call for Information, Bardstown,  Kentucky,  40004,  United States

      Call for Information, Louisville,  Kentucky,  40202,  United States

Massachusetts
      Call for Information, North Dartmouth,  Massachusetts,  02747,  United States

      Call for Information, Wellesley Hills,  Massachusetts,  02481-2106,  United States

Michigan
      Call for Information, Ann Arbor,  Michigan,  48104,  United States

Minnesota
      Call for Information, Minneapolis,  Minnesota,  55402,  United States

Missouri
      Call for Information, Springfield,  Missouri,  65807,  United States

New Jersey
      Call for Information, Edison,  New Jersey,  08817,  United States

      Call for Information, Moorestown,  New Jersey,  08057,  United States

New York
      Call for Information, Mount Vernon,  New York,  10550,  United States

      Call for Information, New York,  New York,  10021,  United States

      Call for Information, Amherst,  New York,  14226,  United States

North Carolina
      Call for Information, Charlotte,  North Carolina,  28211,  United States

      Call for Information, Winston Salem,  North Carolina,  27103,  United States

Ohio
      Call for Information, Cleveland,  Ohio,  44121,  United States

      Call for Information, Westerville,  Ohio,  43081,  United States

      Call for Information, Thornville,  Ohio,  43076,  United States

      Call for Information, West Chester,  Ohio,  45069,  United States

      Call for Information, Cincinnati,  Ohio,  45219,  United States

Oklahoma
      Call for Information, Oklahoma City,  Oklahoma,  73104,  United States

Oregon
      Call for Information, Portland,  Oregon,  97210,  United States

      Call for Information, Eugene,  Oregon,  97401,  United States

Pennsylvania
      Call for Information, Upland,  Pennsylvania,  19013,  United States

Rhode Island
      Call for Information, Cranston,  Rhode Island,  02920,  United States

South Carolina
      Call for Information, Anderson,  South Carolina,  29621,  United States

Texas
      Call for Information, Austin,  Texas,  78705,  United States

      Call for Information, Austin,  Texas,  78705,  United States

      Call for Information, San Antonio,  Texas,  78258,  United States

      Call for Information, Ft. Worth,  Texas,  76135,  United States

Utah
      Call for Information, Salt Lake City,  Utah,  84109,  United States

Virginia
      Call for Information, Charlottesville,  Virginia,  22911,  United States

Washington
      Call for Information, Spokane,  Washington,  99223,  United States

More Information

Study ID Numbers:  2004_089
Record last reviewed:  January 2005
Last Updated:  January 26, 2005
Record first received:  October 29, 2004
ClinicalTrials.gov Identifier:  NCT00095004
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources